Skip to main content
. Author manuscript; available in PMC: 2024 Jan 3.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2023 Jan 3;18(11):769–785. doi: 10.1080/17425255.2022.2160317

Table 4.

Strong and moderate CYP2D6 inhibitors according to US FDA[9]

Type of inhibitors CYP2D6 inhibitors
Strong inhibitors bupropion, fluoxetine, paroxetine, terbinafine, quinidine
Moderate inhibitors abiraterone, cinacalcet, mirabegron, duloxetine, lorcaserin, rolapitant